vitamin A (retinol)
FDA Approved
Description
Vitamin A supplementation is used in the management of retinitis pigmentosa and related retinal degenerative conditions. High-dose vitamin A palmitate has been shown to slow the progression of retinal degeneration in some patients. It is considered a supportive therapy for preserving remaining vision in progressive retinal dystrophies.
Indications & Therapeutic Use
retinitis pigmentosa, retinal degeneration, vitamin A deficiency
Global Availability (5 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
vitamin A (retinol)
| Generic Name | vitamin A (retinol) |
| Brands | 1 brand available |
| Active Ingredient | retinol palmitate |
| Drug Class | retinitis pigmentosa |
| Manufacturer | Various |
| Dosage Forms | oral capsule, 15000 IU; injection solution |
| Medical Code | A11CA01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Countries | 5 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations6 Validated Nodes